[ad_1]
Barclays raised shares of CytomX Therapeutics to a “strong-buy” rating in a report on Tuesday.
[ad_2]
Source link
Related Posts
OpenAI and Meta say they’re fixing AI chatbots to better respond to teens in distress
[ad_1] SAN FRANCISCO (AP) — Artificial intelligence chatbot makers OpenAI and Meta say they are adjusting how their chatbots respond…
National Pension Service Buys 220,892 Shares of Procter & Gamble Company (The) (NYSE:PG)
[ad_1] National Pension Service increased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by…
Quantum Computing (NASDAQ:QUBT) Posts Earnings Results, Meets Expectations
[ad_1] Quantum Computing (NASDAQ:QUBT – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.06) EPS…